Subscribe To
Ac immune sa: ac immune reports first quarter 2023 financial results and provides a corporate update
AC Immune Reports First Quarter 2023 Financial Results and Provides a Corporate Update ACI-24.060 anti-Abeta vaccine showed positive initial safety an...
April 28, 2023, 11:14 am
Moderna shares fall on mixed flu vaccine study results
Moderna Therapeutics Inc (NASDAQ:MRNA) shares have fallen more than 5% in pre-market trading after the biotechnology company reported mixed results fr...
February 17, 2023, 8:52 am
Icosavax provides corporate update and anticipated milestones for 2023
– Recently reported positive six-month immunogenicity data for IVX-121 against RSV; first clinical ev...
January 6, 2023, 1:00 pm
Pfizer and biontech get fda fast track designation for single-dose covid and flu vaccine candidate
Pfizer Inc. PFE, +3.07% and German partner BioNTech SE BNTX, +5.64% said Friday they have received fast track designation from the U.S. Food and Drug ...
December 9, 2022, 6:54 am
Hillevax announces positive immunogenicity results for run-in cohort of nest-in1 phase 2b clinical trial of hil-214 norovirus vaccine candidate
BOSTON, Dec. 05, 2022 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commerc...
December 5, 2022, 11:30 am
Krystal biotech to present additional data on b-vec from the gem-3 phase 3 study at the society for investigative dermatology annual meeting
PITTSBURGH, May 19, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the leader in redosable gene therapy, is please...
May 19, 2022, 7:30 pm
Why icosavax's shares are trading lower today
Icosavax Inc (NASDAQ: ICVX) has announced topline interim results from its ongoing Phase 1/2 trial of IVX-411, a VLP vaccine candidate displaying t...
March 25, 2022, 9:16 am
Valneva's covid-19 shot fails as booster in pfizer/biontech vaccinated population
Valneva SE (NASDAQ: VALN) has responded to data published from the U.K COV-Boost COVID-19 vaccine trial that investigated the reactogenicity and ...
December 3, 2021, 1:31 pm
Valneva's covid-19 shot fails as booster in pfizer/biontech vaccinated population
Valneva SE (NASDAQ: VALN) has responded to data published from the U.K COV-Boost COVID-19 vaccine trial that investigated the reactogenicity and ...
December 3, 2021, 1:31 pm
Valneva's covid-19 shot fails as booster in pfizer/biontech vaccinated population
Valneva SE (NASDAQ: VALN) has responded to data published from the U.K COV-Boost COVID-19 vaccine trial that investigated the reactogenicity and ...
December 3, 2021, 1:31 pm